Act Fast and Take Part in a Humira Study!

JB Editor
  • Infopshere clinical research is working with Abbott Laboratories in the enrollment of participants for the IRB-approved clinical trial investigating the efficacy of a dosage of 80mg adalimumab in the treatment of Rheumatoid arthritis.

    Dr. Stephen R. White, a board certified Rheumatologist, is the primary investigator on this trial.

     

    The researchers are studying whether the a monthly dose of adalimumab 80mg is as good as the bi-weekly dosage of 40mg.

     

    The trial will go on for 24 weeks. A small percentage of participants will be assigned to receive a placebo for the first 12 weeks -- that's how the reseachers will learn if the drug actually works or not.

    Add This Infographic to Your Website or Blog With This Code:

     

    To be eligible, you must meet the following:

    • Be 18 or older
    • Have been diagnosed with Rheumatoid Arthritis for a minimum of three months
    • Is not currently taking any medications for RA (or on a stable dose of MTX)
    • Is in stable health

    Interested?

    The deadline to apply for the trial is Oct. 31!

    Call 818-222-6868 or e-mail Adrienne Scollans, patient relations, at Adrienne@infopshere.md

    They are located in West Hills at 7345 Medical Center Drive, West Hills, CA 91307.

     

    Questions or comments? Call and ask or post them here.

Published On: September 22, 2008